Moreover, because taxane chemotherapy induces cellular stress that often triggers autophagy as a protective mechanism in tumor cells, targeting LC3B-mediated autophagy represents a promising adjuvant strategy to sensitize PC cells to taxanes, potentially enhancing treatment efficacy and reducing recurrence rates [20]. The gene discussed is MAP1LC3B; the disease is pachyonychia congenita.